Angiotech and Argon/RoundTable

Argon Medical Devices, Inc. and their financial backer RoundTable Healthcare Partners acquired the Interventional Products Business of Angiotech Pharmaceuticals.

Theragenics and Juniper

Juniper Investment Company‘s most recent offer of $2.25 to $2.30 per share for Theragenics, Inc. (NYSE:TGX) at $70 to $72 million overall.

Read entire advisory here.

Comments are closed.